FDA approves first GMO Flu Vaccine containing Reprogrammed Insect Virus

FDA approves first GMO Flu Vaccine containing Reprogrammed Insect Virus



A new vaccine for influenza has hit
the market, and it is the first ever to contain genetically-modified
(GM) proteins derived from insect cells. According to reports, the U.S.
Food and Drug Administration (FDA) recently approved the vaccine, known
as Flublok, which contains recombinant DNA technology and an insect
virus known as baculovirus that is purported to help facilitate the more
rapid production of vaccines.

According to Flublok’s package insert,
the vaccine is trivalent, which means it contains GM proteins from three
different flu strains. The vaccine’s manufacturer, Protein Sciences
Corporation (PSC), explains that Flublok is produced by extracting cells
from the fall armyworm, a type of caterpillar, and genetically altering
them to produce large amounts of hemagglutinin, a flu virus protein
that enables the flu virus itself to enter the body quickly.

So rather than have to produce vaccines
the “traditional” way using egg cultures, vaccine manufacturers will now
have the ability to rapidly produce large batches of flu virus protein
using GMOs, which is sure to increase profits for the vaccine industry.
But it is also sure to lead to all sorts of serious side effects,
including the deadly nerve disease Guillain-Barre Syndrome (GSB), which
is listed on the shot as a potential side effect.

“If Guillain-Barre Syndrome (GBS) has
occurred within six weeks of receipt of a prior influenza vaccine, the
decision to give Flublock should be based on careful consideration of
the potential benefits and risks,” explains a section of the vaccine’s
literature entitled “Warnings and Precautions.” Other potential side
effects include allergic reactions, respiratory infections, headaches,
fatigue, altered immunocompetence, rhinorrhea, and myalgia.

According to clinical data provided by
PSC in Flublok’s package insert, two study participants actually died
during trials of the vaccine. But the company still insists Flublok is
safe and effective, and that it is about 45 percent effective against
all strains of influenza in circulation, rather than just one or two
strains.

FDA also approves flu vaccine containing dog kidney cells

Back in November, the FDA also approved a new flu vaccine known as
Flucelvax that is actually made using dog kidney cells. A product of
pharmaceutical giant Novartis, Flucelvax also does away with the egg
cultures, and can similarly be produced much more rapidly than
traditional flu vaccines, which means vaccine companies can have it
ready and waiting should the federal government declare a pandemic.

Like Flublok, Flucelvax was made
possible because of a $1 billion, taxpayer-funded grant given by the
U.S. Department of Health and Human Services (HHS) to the vaccine
industry back in 2006 to develop new manufacturing methods for vaccines.
The ultimate goal is to be able to quickly manufacture hundreds of
millions of vaccines for rapid distribution.

Meanwhile, there are reportedly two
other GMO flu vaccines currently under development. One of them, which
is being produced by Novavax, will utilize “bits of genetic material
grown in caterpillar cells called ‘virus-like particles’ that mimic a
flu virus,” according to Reuters.


source:-
http://www.globalresearch.ca/fda-approves-first-gmo-flu-vaccine-containing-reprogrammed-insect-virus/5338052